These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 29284686

  • 1. Role of common hypnotics on the phenotypic causes of obstructive sleep apnoea: paradoxical effects of zolpidem.
    Carberry JC, Fisher LP, Grunstein RR, Gandevia SC, McKenzie DK, Butler JE, Eckert DJ.
    Eur Respir J; 2017 Dec; 50(6):. PubMed ID: 29284686
    [Abstract] [Full Text] [Related]

  • 2. Zopiclone Increases the Arousal Threshold without Impairing Genioglossus Activity in Obstructive Sleep Apnea.
    Carter SG, Berger MS, Carberry JC, Bilston LE, Butler JE, Tong BK, Martins RT, Fisher LP, McKenzie DK, Grunstein RR, Eckert DJ.
    Sleep; 2016 Apr 01; 39(4):757-66. PubMed ID: 26715227
    [Abstract] [Full Text] [Related]

  • 3. Zolpidem increases sleep efficiency and the respiratory arousal threshold without changing sleep apnoea severity and pharyngeal muscle activity.
    Messineo L, Eckert DJ, Lim R, Chiang A, Azarbarzin A, Carter SG, Carberry JC.
    J Physiol; 2020 Oct 01; 598(20):4681-4692. PubMed ID: 32864734
    [Abstract] [Full Text] [Related]

  • 4. Randomized Trial on the Effects of High-Dose Zopiclone on OSA Severity, Upper Airway Physiology, and Alertness.
    Carter SG, Carberry JC, Grunstein RR, Eckert DJ.
    Chest; 2020 Jul 01; 158(1):374-385. PubMed ID: 32197956
    [Abstract] [Full Text] [Related]

  • 5. Effect of 1 month of zopiclone on obstructive sleep apnoea severity and symptoms: a randomised controlled trial.
    Carter SG, Carberry JC, Cho G, Fisher LP, Rollo CM, Stevens DJ, D'Rozario AL, McKenzie DK, Grunstein RR, Eckert DJ.
    Eur Respir J; 2018 Jul 01; 52(1):. PubMed ID: 29976648
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Withdrawal from long-term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia.
    Lähteenmäki R, Neuvonen PJ, Puustinen J, Vahlberg T, Partinen M, Räihä I, Kivelä SL.
    Basic Clin Pharmacol Toxicol; 2019 Mar 01; 124(3):330-340. PubMed ID: 30295409
    [Abstract] [Full Text] [Related]

  • 8. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.
    Mason M, Cates CJ, Smith I.
    Cochrane Database Syst Rev; 2015 Jul 14; (7):CD011090. PubMed ID: 26171909
    [Abstract] [Full Text] [Related]

  • 9. The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomised crossover trial.
    Lim R, Messineo L, Grunstein RR, Carberry JC, Eckert DJ.
    J Physiol; 2021 Sep 14; 599(17):4183-4195. PubMed ID: 34174090
    [Abstract] [Full Text] [Related]

  • 10. Summaries for patients. Improving use of continuous positive airway pressure for obstructive sleep apnea.
    Ann Intern Med; 2009 Nov 17; 151(10):I38. PubMed ID: 19920253
    [No Abstract] [Full Text] [Related]

  • 11. Effect of zolpidem on the efficacy of continuous positive airway pressure as treatment for obstructive sleep apnea.
    Berry RB, Patel PB.
    Sleep; 2006 Aug 17; 29(8):1052-6. PubMed ID: 16944674
    [Abstract] [Full Text] [Related]

  • 12. A double-blind placebo-controlled trial of zopiclone 7.5 mg and temazepam 20 mg in insomnia.
    Ngen CC, Hassan R.
    Int Clin Psychopharmacol; 1990 Jul 17; 5(3):165-71. PubMed ID: 2230060
    [Abstract] [Full Text] [Related]

  • 13. Morphine alters respiratory control but not other key obstructive sleep apnoea phenotypes: a randomised trial.
    Martins RT, Carberry JC, Wang D, Rowsell L, Grunstein RR, Eckert DJ.
    Eur Respir J; 2020 Jun 17; 55(6):. PubMed ID: 32165399
    [Abstract] [Full Text] [Related]

  • 14. Long-term persistence of withdrawal of temazepam, zopiclone, and zolpidem in older adults: a 3-year follow-up study.
    Puustinen J, Lähteenmäki R, Nurminen J, Vahlberg T, Aarnio P, Partinen M, Räihä I, Neuvonen PJ, Kivelä SL.
    BMC Geriatr; 2018 Jun 15; 18(1):142. PubMed ID: 29907085
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold.
    Eckert DJ, Owens RL, Kehlmann GB, Wellman A, Rahangdale S, Yim-Yeh S, White DP, Malhotra A.
    Clin Sci (Lond); 2011 Jun 15; 120(12):505-14. PubMed ID: 21269278
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.